ClinicalTrials.Veeva

Menu

Does Islet Transplantation Eliminate Hypoglycemia?

N

National Center for Research Resources (NCRR)

Status

Unknown

Conditions

Diabetes Mellitus

Treatments

Procedure: Pancreatic Islet Transplantation

Study type

Interventional

Funder types

NIH

Identifiers

NCT00006068
M01RR000036 (U.S. NIH Grant/Contract)
NCRR-M01RR00036-0746

Details and patient eligibility

About

Low blood sugar (hypoglycemia) is a recurrent problem for many people with diabetes. Successful transplantation of clusters (islets) of normal cells, that include those which produce the sugar-lowering hormone insulin, from the pancreas of a person who did not have diabetes into a person with diabetes should eliminate high blood sugar levels. We wish to determine if it will also eliminate low blood sugar. To do so we will give insulin to lower the blood sugar, measure the levels of the hormones that normally raise blood sugar levels (e.g., glucagon and epinephrine) and then stop the insulin and see if blood sugar levels return to normal. Because we anticipate that the transplanted islets will produce insulin, but not glucagon, this study may also tell us if regulated insulin production alone can prevent hypoglycemia in humans.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Clinically stable, insulin dependent islet transplant recipients and matched nondiabetic healthy controls

Trial contacts and locations

0

Loading...

Central trial contact

Philip E. Cryer, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems